These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model". Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136 [No Abstract] [Full Text] [Related]
5. Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models". Belge C; Quarck R; Delcroix M Circulation; 2016 Apr; 133(14):e591. PubMed ID: 27045135 [No Abstract] [Full Text] [Related]
6. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Gagnadoux F; Capron F; Lebeau B Lung Cancer; 2002 May; 36(2):213-5. PubMed ID: 11955658 [TBL] [Abstract][Full Text] [Related]
7. Favorable response to an endothelin receptor antagonist in mitomycin-induced pulmonary veno-occlusive disease with pulmonary capillary hemangiomatosis. Koyama M; Yano T; Kikuchi K; Mizuno M; Nagano N; Hashimoto A; Miura T Int J Cardiol; 2016 Jun; 212():245-7. PubMed ID: 27045880 [No Abstract] [Full Text] [Related]
8. Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension. Chaumais MC; O'Connell C; Savale L; Guignabert C; Perros F; Jaïs X; Sitbon O; Humbert M; Montani D Int J Clin Pharm; 2018 Aug; 40(4):790-794. PubMed ID: 30101375 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C. Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348 [TBL] [Abstract][Full Text] [Related]
10. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation]. Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063 [TBL] [Abstract][Full Text] [Related]
11. Recovery from mitomycin-induced pulmonary arterial hypertension. Botros L; Van Nieuw Amerongen GP; Vonk Noordegraaf A; Bogaard HJ Ann Am Thorac Soc; 2014 Mar; 11(3):468-70. PubMed ID: 24673706 [No Abstract] [Full Text] [Related]
12. [A not so poorly-defined opacity]. Bravos E; Bayle-Bleuez S; Wahart A; Lachèze R; Forest F; Guichard JB; Bertoletti L Rev Mal Respir; 2017 Mar; 34(3):249-252. PubMed ID: 27637324 [TBL] [Abstract][Full Text] [Related]
13. No Good Deed Goes Unpunished: Mitomycin-Induced Pulmonary Venoocclusive Disease and Cancer. De Jesus Perez VA; Zamanian RT Chest; 2021 Mar; 159(3):910-911. PubMed ID: 33678275 [No Abstract] [Full Text] [Related]
14. Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease. Zhang C; Xing Y; Wu X; Jiang Q; Luo X; He W; Liu S; Lu W; Wang J Respir Res; 2024 Jul; 25(1):281. PubMed ID: 39014440 [TBL] [Abstract][Full Text] [Related]
15. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats. Zhang C; Lu W; Luo X; Liu S; Li Y; Zheng Q; Liu W; Wu X; Chen Y; Jiang Q; Zhang Z; Gu G; Chen J; Chen H; Liao J; Liu C; Hong C; Tang H; Sun D; Yang K; Wang J Br J Pharmacol; 2021 Jan; 178(1):217-235. PubMed ID: 33140842 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary veno-occlusive disease developed in a man given long-term treatment with anticancerous agents]. Maemondo M; Ebina A; Saitou K Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):823-8. PubMed ID: 9866989 [TBL] [Abstract][Full Text] [Related]
17. Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope. Borowska H; Arciszewska E; Czauderna P; Sawicki B Folia Morphol (Warsz); 2004 Feb; 63(1):91-3. PubMed ID: 15039909 [TBL] [Abstract][Full Text] [Related]